Beurs gesloten -
Nasdaq
22:30:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2,77
USD
|
+0,36%
|
|
+6,95%
|
-12,89%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
296,3
|
57,92
|
30,24
|
25,17
|
22,48
|
-
|
-
|
Bedrijfswaarde
1 |
296,3
|
57,92
|
30,24
|
25,17
|
22,48
|
22,48
|
22,48
|
K/w-verhouding
|
-38,4
x
|
-1,9
x
|
-0,97
x
|
-0,76
x
|
-0,99
x
|
-1,45
x
|
-3,2
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1.764
x
|
252
x
|
19,9
x
|
12,3
x
|
2,14
x
|
2,18
x
|
0,8
x
|
Bedrijfswaarde/omzet
|
1.764
x
|
252
x
|
19,9
x
|
12,3
x
|
2,14
x
|
2,18
x
|
0,8
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-0,53
x
|
-0,5
x
|
-0,55
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-188%
|
-201%
|
-181%
|
Price to Book
|
-
|
-
|
0,51
x
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
8.297
|
8.357
|
8.376
|
7.915
|
8.116
|
-
|
-
|
Referentieprijs
2 |
35,71
|
6,930
|
3,610
|
3,180
|
2,770
|
2,770
|
2,770
|
Datum van publicatie
|
9/03/21
|
10/03/22
|
1/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
0,168
|
0,23
|
1,523
|
2,051
|
10,51
|
10,3
|
28,27
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-9,816
|
-26,3
|
-31,35
|
-32,04
|
-36,61
|
-36,22
|
-40,87
|
-29,08
|
Operationele Marge
|
-
|
-15.656,55%
|
-13.629,13%
|
-2.103,74%
|
-1.785,18%
|
-344,57%
|
-396,82%
|
-102,86%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-19,64
|
-31,07
|
-31,08
|
-34,06
|
-34,98
|
-39,33
|
-27,4
|
Nettowinst (verlies)
1 |
-
|
-6,314
|
-30,43
|
-31,06
|
-34,03
|
-34,98
|
-39,33
|
-27,4
|
Nettomarge
|
-
|
-3.758,33%
|
-13.230,43%
|
-2.039,53%
|
-1.659,39%
|
-332,75%
|
-381,88%
|
-96,94%
|
WPA
2 |
-
|
-0,9300
|
-3,650
|
-3,710
|
-4,180
|
-2,800
|
-1,910
|
-0,8650
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-
|
-42,34
|
-45,09
|
-40,73
|
FCF-marge
|
-
|
-
|
-
|
-
|
-
|
-402,73%
|
-437,84%
|
-144,08%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
1/06/20
|
9/03/21
|
10/03/22
|
1/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
-
|
0,22
|
0,111
|
-
|
0,497
|
0,512
|
0,691
|
0,527
|
0,007
|
0,826
|
0,1282
|
10,13
|
0,1282
|
0,1282
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-7,497
|
-6,569
|
-7,731
|
-
|
-7,55
|
-8,835
|
-8,035
|
-9,643
|
-8,932
|
-10
|
-10,34
|
-0,6792
|
-11,68
|
-13,52
|
-12,8
|
Operationele Marge
|
-
|
-2.985,91%
|
-6.964,86%
|
-
|
-1.519,11%
|
-1.725,59%
|
-1.162,81%
|
-1.829,79%
|
-127.600%
|
-1.211,14%
|
-8.059,26%
|
-6,71%
|
-9.110,53%
|
-10.545,03%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-7,488
|
-6,277
|
-7,72
|
-
|
-7,251
|
-8,26
|
-7,346
|
-8,96
|
-8,3
|
-9,457
|
-10,16
|
-0,5085
|
-11,53
|
-12,78
|
-12,8
|
Nettowinst (verlies)
1 |
-7,488
|
-5,641
|
-7,72
|
-7,844
|
-7,251
|
-8,247
|
-7,346
|
-8,931
|
-8,3
|
-9,457
|
-10,16
|
-0,5085
|
-11,53
|
-12,78
|
-12,8
|
Nettomarge
|
-
|
-2.564,09%
|
-6.954,95%
|
-
|
-1.458,95%
|
-1.610,74%
|
-1.063,1%
|
-1.694,69%
|
-118.571,43%
|
-1.144,92%
|
-7.924,95%
|
-5,02%
|
-8.987,33%
|
-9.967,06%
|
-
|
WPA
2 |
-0,9000
|
-0,6800
|
-0,9200
|
-0,9400
|
-0,8600
|
-0,9800
|
-0,8900
|
-1,090
|
-1,040
|
-1,170
|
-1,232
|
-0,6400
|
-0,6825
|
-0,7400
|
-1,200
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/11/21
|
10/03/22
|
10/05/22
|
10/08/22
|
14/11/22
|
1/03/23
|
5/05/23
|
9/08/23
|
7/11/23
|
7/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-
|
-42,3
|
-45,1
|
-40,7
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-7,770
|
-
|
-
|
7,120
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
0,02
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
-
|
1,38%
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
1/06/20
|
9/03/21
|
10/03/22
|
1/03/23
|
7/03/24
|
-
|
-
|
-
|
Laatste slotkoers
2,77
USD Gemiddelde koersdoel
23,33
USD Spread / Gemiddelde doel +742,36% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -12,89% | 22,48 mln. | | +1,51% | 42,75 mld. | | +49,22% | 41,61 mld. | | +8,57% | 41,34 mld. | | -12,36% | 26,59 mld. | | +8,92% | 25,49 mld. | | -25,13% | 18,12 mld. | | +29,17% | 12,24 mld. | | -3,12% | 11,76 mld. | | +6,35% | 11 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|